John Waterfallen
Obstetrics & Gynecology · Shreveport, LANPI 1164417309
Payments from drug & device makers
Across 153 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$679
- Lupin Inc.$421
- Amgen$382
- Pfizer$346
- Aspira Women's Health Inc$256
- Daiichi Sankyo Inc.$134
- plus $599 from 17 others
What the payments were for
- Consulting fees$151%
- Food & beverage$2,79599%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $679 |
| Lupin Inc. | 31 | $421 |
| Amgen | 14 | $382 |
| Pfizer | 20 | $346 |
| Aspira Women's Health Inc | 5 | $256 |
| Daiichi Sankyo Inc. | 6 | $134 |
| Therapeuticsmd, Inc. | 7 | $123 |
| Eisai Inc. | 6 | $93 |
| Hologic Sales And Service, LLC | 4 | $68 |
| Scynexis, Inc. | 3 | $56 |
| Novo Nordisk | 3 | $43 |
| Urovant Sciences Inc | 2 | $37 |
| Avion Pharmaceuticals | 2 | $27 |
| Bausch Health US, LLC | 2 | $27 |
| Seqirus USA Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Bayer | 1 | $13 |
| Sage Therapeutics, LLC | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$250
How this compares
$2,817 in reported general payments places this provider in the 70th percentile of 608 obstetrics & gynecology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 14 | $6,776 |
| Estradiol | 62 | $1,536 |
| Medroxyprogesterone Acetate | 12 | $161 |
| Fluoxetine Hcl | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $346 | $6,77614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 608 obstetrics & gynecology providers in Louisiana.
Other obstetrics & gynecology in Shreveport
- Gregory PhillipsShreveport$72K
- Catherine VanderloosShreveport$55K
- Joanna PooleShreveport$24K
- Ricky PaulShreveport$24K
- Erin GullattShreveport$11K
- James RobertsonShreveport$11K
- John HaynesShreveport$9K
- Kristy WaltmanShreveport$7K
- Alison RodriguezNew Orleans$10.5M
- Scott StriplinCovington$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.